These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 33919751)

  • 1. Research Updates for Influenza Virus and Vaccine Development.
    Plant EP; Xie H
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33919751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies.
    Huang L; Rong Y; Pan Q; Yi K; Tang X; Zhang Q; Wang W; Wu J; Wang F
    Asian J Pharm Sci; 2021 Mar; 16(2):136-146. PubMed ID: 32905011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Zhang C; Zhou C; Shi L; Liu G
    Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic.
    Mandal H
    Turk J Med Sci; 2020 Apr; 50(SI-1):485-488. PubMed ID: 32299208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
    Ietto G
    Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current updates and research on plant-based vaccines for coronavirus disease 2019.
    Uthaya Kumar A; Kadiresen K; Gan WC; Ling APK
    Clin Exp Vaccine Res; 2021 Jan; 10(1):13-23. PubMed ID: 33628750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.
    Huang SW; Tai CH; Hsu YM; Cheng D; Hung SJ; Chai KM; Wang YF; Wang JR
    Biomed J; 2020 Aug; 43(4):375-387. PubMed ID: 32611537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana.
    Miatech JL; Tarte NN; Katragadda S; Polman J; Robichaux SB
    Respir Med Case Rep; 2020; 31():101214. PubMed ID: 32923361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioethical Implications in Vaccine Development, a COVID-19 Challenge.
    Ospina Henao S; Marín Mora A; Chan Solano F; Ávila-Aguero ML
    Cureus; 2020 Sep; 12(9):e10530. PubMed ID: 33101792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza.
    Seki M
    World J Virol; 2021 Mar; 10(2):62-68. PubMed ID: 33816151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in Thyroid Cancer Surgery.
    Sorrenti S; Calò PG
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.